Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-14 Option Award |
2023-02-16 6:20 pm |
N/A 2033-02-13 |
IMPEL PHARMACEUTICALS INC | IMPL | Leaman John Harold Chief Fin. & Business Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-04 6:46 pm |
N/A N/A |
IMPEL PHARMACEUTICALS INC | IMPL | Leaman John Harold Chief Fin. & Business Officer |
10,571 | $0 | 6,944 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 6:46 pm |
N/A N/A |
IMPEL PHARMACEUTICALS INC | IMPL | Leaman John Harold Chief Fin. & Business Officer |
3,627 | $3.75 | 6,944 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 5:04 pm |
N/A 2032-01-25 |
IMPEL NEUROPHARMA INC | IMPL | Leaman John Harold Chief Fin. & Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-21 5:31 pm |
N/A 2031-10-19 |
IMPEL NEUROPHARMA INC | IMPL | Leaman John Harold Chief Fin. & Business Officer |
10,571 | $0 | 10,571 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-26 6:00 pm |
N/A 2031-07-19 |
IMPEL NEUROPHARMA INC | IMPL | Leaman John Harold Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2021-04-22 7:06 pm |
N/A 2029-06-23 |
IMPEL NEUROPHARMA INC | IMPL | Leaman John Harold Chief Financial Officer |
0 | $0 | 256,549 (Direct) |
View |